Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1945765
                    [Title] => Dengvaxia appeal rejected, but options open
                    [Summary] => The Department of Health (DOH) has rejected the appeal of pharmaceutical company Sanofi Pasteur to allow Dengvaxia into the local market due to failure to secure requirements.
                    [DatePublished] => 2019-08-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-sanofi_2019-08-22_23-26-01161_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1945520
                    [Title] => DOH swats down Sanofi appeal to lift Dengvaxia ban
                    [Summary] => The Department of Health denied the appeal of pharmaceutical firm Sanofi Pasteur to lift the ban on Dengvaxia—the controversial vaccine the company said would protect against dengue.  
                    [DatePublished] => 2019-08-22 15:02:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-kj-rosales2019-08-0300-01-31_2019-08-22_14-44-50553_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1939727
                    [Title] => Rise in dengue, measles cases underline value of vaccines
                    [Summary] => The Philippines is facing two public health crises in 2019—a simmering measles outbreak and the soaring number of dengue cases.


                    [DatePublished] => 2019-08-01 12:07:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805246
                    [AuthorName] => Gaea Katreena Cabico
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/01/110219vaccine03kjrosales_2019-08-01_11-48-19125_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1895030
                    [Title] => Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration
                    [Summary] => With the revocation of Dengvaxia, it is now unlawful to import, sell or distribute the said products.
                    [DatePublished] => 2019-02-19 18:32:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/02/19/dengvaxia-vaccines_2019-02-19_18-14-38826_thumbnail.jpg
                )

            [4] => Array
                (
                    [ArticleID] => 1865867
                    [Title] => DOJ set to release Dengvaxia probe results
                    [Summary] => Families of schoolchildren who died allegedly due to the controversial Dengvaxia vaccine may soon find an answer to their cry for justice.
                    [DatePublished] => 2018-11-05 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804827
                    [AuthorName] => Edu Punay
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => http://media.philstar.com/images/articles/nat2-families-dengvaxia-victim_2018-11-04_20-11-25653_thumbnail.jpg
                )

            [5] => Array
                (
                    [ArticleID] => 1862098
                    [Title] => Dengvaxia seen to get EU accreditation
                    [Summary] => Despite the controversy in the Philippines, Dengvaxia has moved a step closer to becoming the first accredited vaccine against dengue in the European Union (EU).
                    [DatePublished] => 2018-10-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804761
                    [AuthorName] => Helen Flores
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen4-dengvaxia-box-ap_2018-10-21_22-21-29277_thumbnail.jpg
                )

            [6] => Array
                (
                    [ArticleID] => 1849092
                    [Title] => Senate approves  P1.16-billion supplemental budget for dengue assistance
                    [Summary] => The Senate has approved on third and final reading the P1.161-billion supplemental budget for assistance to people injected with the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-09-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804867
                    [AuthorName] => Marvin Sy
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen11-house-senate-geremy-pintolo_2018-09-05_22-25-37995_thumbnail.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 1847066
                    [Title] => ‘Sanofi’s P1.16-billion refund should be for Dengvaxia kids’
                    [Summary] => Health Secretary Francisco Duque III urged the Senate yesterday to pass a supplemental budget earmarking the P1.16 billion returned by pharmaceutical firm Sanofi Pasteur to assist children vaccinated with Dengvaxia.
                    [DatePublished] => 2018-08-30 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-francisco-duque-boy-santos_2018-08-29_22-19-57395_thumbnail.jpg
                )

            [8] => Array
                (
                    [ArticleID] => 1825088
                    [Title] => DOH not resuming Dengvaxia program
                    [Summary] => The Department of Health is unlikely to resume the anti-dengue immunization campaign using the controversial Dengvaxia vaccine even if the drug provides protection to people who have been previously infected with the mosquito-borne disease.
                    [DatePublished] => 2018-06-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-dengvaxia-box_2018-06-15_22-14-43_thumbnail.jpg
                )

            [9] => Array
                (
                    [ArticleID] => 1822343
                    [Title] => DOH urged to demand P3-billion refund from Dengvaxia maker
                    [Summary] => Health officials have been asked to demand P3 billion in full refund from French pharmaceutical giant Sanofi Pasteur for the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-06-07 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804863
                    [AuthorName] => Jess Diaz
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen9-sanofi-pasteur-officials_2018-06-06_23-05-52690_thumbnail.jpg
                )

        )

)

Sanofi Pasteur

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1945765
                    [Title] => Dengvaxia appeal rejected, but options open
                    [Summary] => The Department of Health (DOH) has rejected the appeal of pharmaceutical company Sanofi Pasteur to allow Dengvaxia into the local market due to failure to secure requirements.
                    [DatePublished] => 2019-08-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-sanofi_2019-08-22_23-26-01161_thumbnail.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1945520
                    [Title] => DOH swats down Sanofi appeal to lift Dengvaxia ban
                    [Summary] => The Department of Health denied the appeal of pharmaceutical firm Sanofi Pasteur to lift the ban on Dengvaxia—the controversial vaccine the company said would protect against dengue.  
                    [DatePublished] => 2019-08-22 15:02:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/22/gen2-dengvaxia-kj-rosales2019-08-0300-01-31_2019-08-22_14-44-50553_thumbnail.jpg
                )

            [2] => Array
                (
                    [ArticleID] => 1939727
                    [Title] => Rise in dengue, measles cases underline value of vaccines
                    [Summary] => The Philippines is facing two public health crises in 2019—a simmering measles outbreak and the soaring number of dengue cases.


                    [DatePublished] => 2019-08-01 12:07:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1805246
                    [AuthorName] => Gaea Katreena Cabico
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/08/01/110219vaccine03kjrosales_2019-08-01_11-48-19125_thumbnail.jpg
                )

            [3] => Array
                (
                    [ArticleID] => 1895030
                    [Title] => Sanofi Pasteur appeals Philippines revocation of Dengvaxia’s certificate of product registration
                    [Summary] => With the revocation of Dengvaxia, it is now unlawful to import, sell or distribute the said products.
                    [DatePublished] => 2019-02-19 18:32:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => https://media.philstar.com/photos/2019/02/19/dengvaxia-vaccines_2019-02-19_18-14-38826_thumbnail.jpg
                )

            [4] => Array
                (
                    [ArticleID] => 1865867
                    [Title] => DOJ set to release Dengvaxia probe results
                    [Summary] => Families of schoolchildren who died allegedly due to the controversial Dengvaxia vaccine may soon find an answer to their cry for justice.
                    [DatePublished] => 2018-11-05 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804827
                    [AuthorName] => Edu Punay
                    [SectionName] => Nation
                    [SectionUrl] => nation
                    [URL] => http://media.philstar.com/images/articles/nat2-families-dengvaxia-victim_2018-11-04_20-11-25653_thumbnail.jpg
                )

            [5] => Array
                (
                    [ArticleID] => 1862098
                    [Title] => Dengvaxia seen to get EU accreditation
                    [Summary] => Despite the controversy in the Philippines, Dengvaxia has moved a step closer to becoming the first accredited vaccine against dengue in the European Union (EU).
                    [DatePublished] => 2018-10-22 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804761
                    [AuthorName] => Helen Flores
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen4-dengvaxia-box-ap_2018-10-21_22-21-29277_thumbnail.jpg
                )

            [6] => Array
                (
                    [ArticleID] => 1849092
                    [Title] => Senate approves  P1.16-billion supplemental budget for dengue assistance
                    [Summary] => The Senate has approved on third and final reading the P1.161-billion supplemental budget for assistance to people injected with the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-09-06 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804867
                    [AuthorName] => Marvin Sy
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen11-house-senate-geremy-pintolo_2018-09-05_22-25-37995_thumbnail.jpg
                )

            [7] => Array
                (
                    [ArticleID] => 1847066
                    [Title] => ‘Sanofi’s P1.16-billion refund should be for Dengvaxia kids’
                    [Summary] => Health Secretary Francisco Duque III urged the Senate yesterday to pass a supplemental budget earmarking the P1.16 billion returned by pharmaceutical firm Sanofi Pasteur to assist children vaccinated with Dengvaxia.
                    [DatePublished] => 2018-08-30 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804896
                    [AuthorName] => Sheila Crisostomo
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-francisco-duque-boy-santos_2018-08-29_22-19-57395_thumbnail.jpg
                )

            [8] => Array
                (
                    [ArticleID] => 1825088
                    [Title] => DOH not resuming Dengvaxia program
                    [Summary] => The Department of Health is unlikely to resume the anti-dengue immunization campaign using the controversial Dengvaxia vaccine even if the drug provides protection to people who have been previously infected with the mosquito-borne disease.
                    [DatePublished] => 2018-06-16 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804856
                    [AuthorName] => Mayen Jaymalin
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen7-dengvaxia-box_2018-06-15_22-14-43_thumbnail.jpg
                )

            [9] => Array
                (
                    [ArticleID] => 1822343
                    [Title] => DOH urged to demand P3-billion refund from Dengvaxia maker
                    [Summary] => Health officials have been asked to demand P3 billion in full refund from French pharmaceutical giant Sanofi Pasteur for the controversial Dengvaxia vaccine.
                    [DatePublished] => 2018-06-07 00:00:00
                    [ColumnID] => 0
                    [Focus] => 1
                    [AuthorID] => 1804863
                    [AuthorName] => Jess Diaz
                    [SectionName] => Headlines
                    [SectionUrl] => headlines
                    [URL] => http://media.philstar.com/images/articles/gen9-sanofi-pasteur-officials_2018-06-06_23-05-52690_thumbnail.jpg
                )

        )

)

abtest